Review: Angiotensin II receptor blocker plus angiotensin-converting enzyme inhibitor increases risk for adverse effects
2020 ◽
Vol 132
◽
pp. 150-157
◽
2019 ◽
Vol 25
(3)
◽
pp. 358-365
◽
2006 ◽
Vol 29
(7)
◽
pp. 747-752
◽
2009 ◽
Vol 27
(Suppl 5)
◽
pp. S23-S29
◽